Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mari Sekiguchi"'
Autor:
Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Michio Nakamura, Osamu Muto, Susumu Sogabe, Yoshiaki Shindo, Atsushi Ishiguro, Atsushi Sato, Yasushi Tsuji, Masayoshi Dazai, Hiroyuki Okuda, Takashi Meguro, Kazuaki Harada, Mari Sekiguchi, Kazufumi Okada, Yoichi M Ito, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
The Oncologist. 27(8):e642-e649
Background Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan c
Autor:
Susumu Sogabe, Takahide Sasaki, Atsushi Sato, Yoshito Komatsu, Michio Nakamura, Hiroyuki Okuda, Atsushi Ishiguro, Kentaro Sawada, Satoshi Yuki, Ysohiaki Shindo, Naoya Sakamoto, Kazuaki Harada, Masayoshi Dazai, Yasuyuki Kawamoto, Yuh Sakata, Mari Sekiguchi, Hiroshi Nakatsumi, Yasushi Tsuji, Osamu Muto, Shintaro Nakano
Publikováno v:
Annals of Oncology. 32:S314
Autor:
Atsushi Sato, Yasushi Tsuji, Takahide Sasaki, Shintaro Nakano, Susumu Sogabe, Atsushi Ishiguro, Hiroshi Nakatsumi, Satoshi Yuki, Yoshito Komatsu, Masayoshi Dazai, Osamu Muto, Yuh Sakata, Hiroyuki Okuda, Kentaro Sawada, Kazuaki Harada, Naoya Sakamoto, Mari Sekiguchi, Yasuyuki Kawamoto, Michio Nakamura, Yoshiaki Shindo
Publikováno v:
Journal of Clinical Oncology. 39:217-217
217 Background: Ramucirumab (RAM) is a fully human IgG1 monoclonal vascular endothelial growth factor receptor-2 (VEGFR-2) antibody. The RAINBOW trial showed RAM plus paclitaxel (PTX) increased overall survival (OS) compared with PTX alone for advanc
Autor:
Shintaro Nakano, Tomoyuki Ohta, Koichi Furukawa, Kyoko Kato, Kazuteru Hatanaka, Hiroshi Nakatsumi, Yasuyuki Kawamoto, Shunsuke Kato, Junta Nakajima, Atsushi Ishiguro, Kazunori Eto, Takayuki Ando, Mari Sekiguchi, Satoshi Yuki, Yasuo Komatsu, Susumu Sogabe, Masafumi Nakamura, Kenji Suzuki, M. Tateyama, Y. Sakata
Publikováno v:
Annals of Oncology. 29:ix32-ix33
Publikováno v:
Journal of Insect Biotechnology & Sericology; 2020, Vol. 89 Issue 3, p45-53, 9p
Autor:
Noriyuki Sueyoshi, Naoya Hatano, Yasushi Shigeri, Syouichi Katayama, Isamu Kameshita, Mari Sekiguchi
Publikováno v:
Archives of Biochemistry and Biophysics. 535:257-267
Cyclin-dependent kinase-like 5 (CDKL5) is a Ser/Thr protein kinase predominantly expressed in brain and mutations of its gene are known to be associated with neurodevelopmental disorders such as X-linked West syndrome and Rett syndrome. However, the
Autor:
Kazuteru Hatanaka, Hiroki Yoshita, Kazunori Eto, Chiaki Asada, Hiroshi Nakatsumi, Kanji Kato, Shinya Minami, Satoshi Yuki, Miki Tateyama, Yoshito Komatsu, Yuh Sakata, Mari Sekiguchi, Tomoyuki Ohta, Yasushi Tsuji, T. Saiki, Atsushi Ishiguro, Kazuhiro Suzuki, Masahiko Koike, Michio Nakamura, Junta Nakajima
Publikováno v:
Journal of Clinical Oncology. 36:832-832
832 Background: The J003 trial and RECOURSE trial revealed the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer (mCRC). In March 2014, TAS-102 was approved in Japan. However, in these pivotal trials, there were few cases
Publikováno v:
RO-MAN
We propose a wearable guide system for supporting the visually impaired. A wearable device equipped with a small laser range sensor and a gyroscope as sensors is developed. The sensors are attached to the user's chest. The range sensor is utilized to
Autor:
Mari, Sekiguchi
Publikováno v:
史苑. 60(1):152-166
Publikováno v:
2013 IEEE International Conference on Mechatronics and Automation.
We proposes a step detection system as a supporting system for the visually impaired. A small laser range sensor, which is attached to the user's chest, obtains distance information in the vertical cross-sectional plane of the front of the user. Poin